Navigation Links
iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming
Date:7/7/2009

urodegenerative disease.
  • Dr. Matthias Hebrok, Hurlbut-Johnson Distinguished Professor in Diabetes Research, is professor of Medicine and associate director for research at the Diabetes Center at UCSF. The main focus of his lab is to understand how islets of Langerhans, the endocrine component of the pancreas, are formed during organogenesis, how their function is regulated in the mature organism, and how changes in gene expression might allow islet regeneration.
  • Dr. Amy Wagers, assistant professor in the Section on Developmental and Stem Cell Biology at Joslin Diabetes Center and the Department of Stem Cell and Regenerative Biology at Harvard University, and principal faculty member of the Harvard Stem Cell Institute. Dr. Wagers is a leading expert in adult stem cells of skeletal muscle and bone marrow.

  • About iPierian

    iPierian is a South San Francisco-based biopharmaceutical company focused on the industrialization of induced pluripotent stem cell (iPS) technology with the mission of creating new therapeutics through cellular reprogramming and directed differentiation of patient cells. iPierian is backed by Kleiner Perkins Caufield & Byers, Highland Capital Partners, MPM Capital and FinTech Global Capital. The initial focus of the company is in neurodegeneration, particularly spinal muscular atrophy (SMA), amyotrophic lateral sclerosis (ALS) and Parkinson's disease as well as in cardiovascular disease, where iPierian has a collaboration with The Gladstone Institute of Cardiovascular Disease and Dr. Deepak Srivastava, the institute's director. iPierian plans to enhance its partnership efforts to further expand into metabolic diseases. The company recently announced a formal collaboration with the laboratory of Dr. Shinya Yamanaka of Kyoto University to develop and improve methods of deriving iPS cell lines in order to advance iPS cell te
    '/>"/>

    SOURCE iZumi Bio, Inc.; Pierian, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related biology technology :

    1. The Gladstone Institutes and iZumi Bio Announce Broad Partnership in Regenerative Medicine and Cardiovascular Disease
    2. iZumi Bio, Inc. Recruits Leading iPS Scientist, John Dimos, to Translate Stem Cell Breakthrough Into Patient Benefits
    3. iZumi Bio, Inc., Appoints John Walker as Chief Executive Officer
    4. iZumi Bio Appoints Dr. Berta Strulovici as Chief Technology Officer and Dr. Dushyant Pathak as Vice President of Business Development
    5. iZumi Bio Appoints Dr. Corey Goodman to Board of Directors and Scientific Advisory Board
    6. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
    7. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
    8. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
    9. ev3 and FoxHollow Announce Date for Special Meeting of FoxHollow Stockholders to Vote on Proposed Merger
    10. IsoTis - Integra Merger
    11. New Brunswick Scientific Completes Merger Transaction with Eppendorf
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)... 2014 Earlier this year in a June ... the Adult Stem Cell Technology Center, LLC ( ASCTC ) ... property of adult tissue stem cells. His title “Asymmetric ... for the Future,” embodied the essence of his message to ...
    (Date:12/24/2014)... 2014 On Friday, December 19, 2014, ... and Continuing Resolution Appropriations Act of 2015, which for ... receive funding through the Congressionally Directed Medical Research Programs ... Hydrocephalus Association (HA), working in conjunction with its allies ...
    (Date:12/24/2014)... Texas (PRWEB) December 23, 2014 ... such as its definition, classification, application and industry ... process, and product cost structure. Production is separated ... covers upstream raw materials, equipment, downstream client survey, ...
    (Date:12/24/2014)... 24, 2014 The report expects global cell ... It also provides a carefully analyzed data about the vital ... , Full Copy of Report @ http://bit.ly/1yUxy0T , ... will keep witnessing growth at an impressive CAGR during near ...
    Breaking Biology Technology:Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4Rare Brain Condition Now Eligible for Department of Defense Research Dollars 2Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 3
    ... Treatment of Opioid ... Bowel ... NKTR ) presented results today at the American College,of ... trial of NKTR-118 (oral PEG-naloxol). NKTR-118 is Nektar,s,proprietary investigational treatment ...
    ... 10 BioStorage Technologies, Inc.,(BST) announced that it ... Company (IPL) to purchase electricity generated by 100 ... voluntary,program. By offsetting the use of fossil-fueled power ... completely carbon-neutral by 2009. BST becomes the ...
    ... HILLS, Ill. and DUBLIN, Ireland, Sept. 10 /PRNewswire-FirstCall/,-- ... TTPA ), today,announced the launch of its newly ... markedly improves the ability of,visitors to quickly find ... single source of information for financial,professionals in the ...
    Cached Biology Technology:Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting 2Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting 3Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting 4Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting 5BioStorage Technologies Becomes Green Powered through the Use of 100% Certified Renewable Energy 2BioStorage Technologies Becomes Green Powered through the Use of 100% Certified Renewable Energy 3BioStorage Technologies Becomes Green Powered through the Use of 100% Certified Renewable Energy 4Concuity Announces the Launch of Its New Fully Accessible Website - Concuity.Com 2Concuity Announces the Launch of Its New Fully Accessible Website - Concuity.Com 3
    (Date:12/19/2014)... Calif. , Dec. 18, 2014  23andMe, Inc., the leading ... that pinpoints fine-scale differences in genetic ancestry of individuals from ... Since immigrants first arrived more than four hundred years ago, ... a meeting place for peoples from different continents. This study ...
    (Date:12/17/2014)... Dec. 15, 2014  HITLAB SM announced today its ... confirm its adherence to current U.S. Food and Drug ... regulated smart device and smart phone application trials utilizing ... "HITLAB is determined to improve global healthcare ...
    (Date:12/15/2014)... , Dec. 12, 2014 Research and Markets ... the "Global Facial Recognition Market 2015-2019" report ... Facial recognition is a technology used ... the overall facial feature of a person such as ...
    Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
    ... international public-private research team led by scientists at the ... construction and availability of an extensive library of molecular ... As described in the March 24 issue of Cell, ... switch off genes individually, allowing the user to dissect ...
    ... language sparking the dramatic evolutionary growth of the human ... for fun, but for food. , According to Dr. ... diet that fuelled and provided the essential nutrients to ... to Dr. Cunnane our initial brain boost didn't happen ...
    ... in all US states for West Nile virus (WNV) makes little ... Columbia University and Harvard School of Public Health. , And ... about mosquitoes, it seems a good time to take a look ... to ensure that the best policy is in place for the ...
    Cached Biology News:New RNAi tools enable systematic studies of gene function 2New RNAi tools enable systematic studies of gene function 3There's something fishy about human brain evolution 2There's something fishy about human brain evolution 3Screening blood for West Nile virus 2
    ... The thermostable dUTPase(pyrococcus fruriosus) ... (using proofreading DNA polymerases). It ... reactions and dNTP solutions. The ... DNA polymerase reaction can prevent dUTP ...
    ... AVOID FREEZE/THAW CYCLES. An assay kit designed ... Western blotting. PARP is an enzyme implicated ... apoptosis, PARP is cleaved by caspase-3. Cleavage ... to 85 kDa is a hallmark of ...
    ... save space and organize gloves, ... other garb. They are the ... small parts used in labs, ... Many other sizes and custom ...
    ... save space and organize gloves, ... other garb. They are the ... small parts used in labs, ... Open-slot design for easy cleaning. ...
    Biology Products: